Intra-Cellular Therapies
2025
Johnson & Johnson
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
Johnson & Johnson
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
Acquisitions
3
Total Acquisitions
2025
2024
2023
The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.
Johnson & Johnson has made major acquisitions across pharmaceuticals and MedTech, including Shockwave Medical and Intra-Cellular Therapies in the current era.
They show how the company added scale, capabilities, customers, or portfolio focus over time.
J&J relies on wholesalers, hospitals, physicians, suppliers, research partners, regulators, and health systems.